Nature Biotechnology has in its August edition an article about bioprospecting in the Arctic.
Biotec Marine Biochemicals is actively taking part in this challenging research, and ...
Settlement between Biotec Pharmacon ASA and Biothera
Published 17.08.2009
Biothera and Biotec Pharmacon ASA announce they have reached a settlement of the litigation between them now pending in federal court in Minneapolis, Minnesota. Although the terms ...
Phase III oral mucositis study proceeds as planned after interim analysis
Published 10.08.2009
Biotec Pharmacon will proceed as planned with its first phase III study with SBG for oral mucosits, following the recommendation from an independent statistician who has performed ...
U.S patent court case scheduled for 14 September 2009
Published 16.07.2009
Biotec Pharmacon has been informed by the U.S. District Court, District of Minnesota that the case regarding the remaining outstanding patent issues with Biothera has been schedule...
Jan Buch Andersen heading up newly established Biotec Marine Biochemicals AS
Published 17.06.2009
Biotec Pharmacon ASA has moved all its enzyme activities into Biotec Marine Biochemicals AS and hired Jan Buch Andersen as Managing Director of the newly established subsidiary. Th...
Phase III diabetic ulcer program proceeds as planned after interim analysis
Published 11.05.2009
The independent statistician responsible for the interim analysis of the second of the two phase III studies with SBG for diabetic foot ulcers recommends that Biotec Pharmacon proc...
Completed patient inclusion in both phase III diabetic ulcer studies
Published 31.03.2009
Biotec Pharmacon has included 130 patients and reached the planned size in the second of its two phase III studies with SBG for treatment of diabetic foot ulcer. An interim analysi...
Completed patient inclusion in the first phase III diabetic ulcer study
Published 17.03.2009
Biotec Pharmacon has reached a significant milestone with completion of patient inclusion in the first of two phase III studies with SBG for treatment of diabetic foot ulcer. A tot...
U.S District Court confirms positive patent case ruling in favour of Biotec Pharmacon
Published 12.02.2009
Biothera has been denied permission to file a motion to reconsider the U.S District Court Order of 28 January, 2009, which largely ruled in Biotec Pharmacon’s favour in a patent in...
